Skip to main content
. 2018 Sep 6;4(11):1543–1552. doi: 10.1001/jamaoncol.2018.3676

Figure 2. Scatterplots With Response According to Delta Tumor Growth Rate (TGR) in the Immunotherapy and Chemotherapy Cohorts.

Figure 2.

A, Light blue spots show 266 patients with regressing or stable tumors, dark blue spots show 78 patients with progressing tumors, and orange spots show 62 patients with accelerated tumor growth during programmed cell death (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitor therapy. B, Light blue spots show 47 patients with regressing or stable tumors, dark blue spots show 9 patients with progressing tumors, and orange spots show 3 patients with accelerated tumor growth during chemotherapy. Diagonal lines separate patients with delta TGR exceeding 50% from patients with delta TGR of 50% or less.